Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2016 1
2020 2
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Adherence to omalizumab: A multicenter "real-world" study.
Campisi R, Crimi C, Intravaia R, Strano S, Noto A, Foschino MP, Valenti G, Viviano V, Pelaia C, Ricciardi L, Scichilone N, Crimi N. Campisi R, et al. Among authors: valenti g. World Allergy Organ J. 2020 Feb 12;13(2):100103. doi: 10.1016/j.waojou.2020.100103. eCollection 2020 Feb. World Allergy Organ J. 2020. PMID: 32082464 Free PMC article.
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
Bongiorno MR, Crimi N, Corrao S, Allotta A, Arena A, Brusca I, Heffler E, Malara G, Milioto M, Pistone G, Porto M, Raia E, Valenti G. Bongiorno MR, et al. Among authors: valenti g. Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6. Ann Allergy Asthma Immunol. 2016. PMID: 27720581 Review. No abstract available.
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.
Pelaia C, Crimi C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta D, D'Amato M, Macchia L, Nolasco S, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Valenti G, Vatrella A, Crimi N. Pelaia C, et al. Among authors: valenti g. J Asthma Allergy. 2021 Feb 22;14:163-173. doi: 10.2147/JAA.S297273. eCollection 2021. J Asthma Allergy. 2021. PMID: 33654413 Free PMC article.
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma.
Pelaia C, Crimi C, Crimi N, Ricciardi L, Scichilone N, Valenti G, Bonavita O, Andaloro S, Morini P, Rizzi A, Pelaia G. Pelaia C, et al. Among authors: valenti g. Expert Rev Respir Med. 2022 Feb;16(2):183-195. doi: 10.1080/17476348.2021.2011222. Epub 2021 Dec 23. Expert Rev Respir Med. 2022. PMID: 34845963
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study.
Nolasco S, Crimi C, Pelaia C, Benfante A, Caiaffa MF, Calabrese C, Carpagnano GE, Ciotta D, D'Amato M, Macchia L, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Spadaro G, Campisi R, Valenti G, Vatrella A, Crimi N. Nolasco S, et al. Among authors: valenti g. J Allergy Clin Immunol Pract. 2021 Dec;9(12):4371-4380.e4. doi: 10.1016/j.jaip.2021.08.004. Epub 2021 Aug 19. J Allergy Clin Immunol Pract. 2021. PMID: 34419679
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis.
Di Bona D, Crimi C, D'Uggento AM, Benfante A, Caiaffa MF, Calabrese C, Campisi R, Carpagnano GE, Ciotta D, D'Amato M, Pelaia C, Pelaia G, Pellegrino S, Scichilone N, Scioscia G, Ribecco N, Spadaro G, Valenti G, Vatrella A, Crimi N, Macchia L. Di Bona D, et al. Among authors: valenti g. Clin Exp Allergy. 2022 Feb;52(2):312-323. doi: 10.1111/cea.14026. Epub 2021 Oct 16. Clin Exp Allergy. 2022. PMID: 34608696
11 results